1	Joven	joven	NCCS000	C0332239	calificador	0-5	144_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	144_QUEST_clinical_caseMIR	SENT1	-	-
3	26	26		-	-	9-11	144_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	144_QUEST_clinical_caseMIR	SENT1	-	-
5	natural	natural	AQ0CS0	C0205296	calificador	17-24	144_QUEST_clinical_caseMIR	SENT1	-	-
6	de	de	SPS00	C0332285	atributo	25-27	144_QUEST_clinical_caseMIR	SENT1	-	-
7	Guayaquil	guayaquil	AQ0CS0	-	-	28-37	144_QUEST_clinical_caseMIR	SENT1	-	-
8	(	(	Fpa	-	-	38-39	144_QUEST_clinical_caseMIR	SENT1	-	-
9	Ecuador	ecuador	NCMS000	-	-	39-46	144_QUEST_clinical_caseMIR	SENT1	-	-
10	)	)	Fpt	-	-	46-47	144_QUEST_clinical_caseMIR	SENT1	-	-
11	,	,	Fc	-	-	47-48	144_QUEST_clinical_caseMIR	SENT1	-	-
12	residente	residente	NCCS000	C0439848	calificador	49-58	144_QUEST_clinical_caseMIR	SENT1	-	-
13	en	en	SPS00	C1720294#C0332285	calificador#atributo	59-61	144_QUEST_clinical_caseMIR	SENT1	-	-
14	España	españa	NC00SC0	C0037747	localización_geográfica	62-68	144_QUEST_clinical_caseMIR	SENT1	-	-
15	desde	desde	SPS00	-	-	69-74	144_QUEST_clinical_caseMIR	SENT1	-	-
16	hace	hacer	VMIP3S0	-	-	75-79	144_QUEST_clinical_caseMIR	SENT1	-	-
17	10	10		-	-	80-82	144_QUEST_clinical_caseMIR	SENT1	-	-
18	años	año	NCMP000	C0439234	calificador	83-87	144_QUEST_clinical_caseMIR	SENT1	-	-
19	,	,	Fc	-	-	87-88	144_QUEST_clinical_caseMIR	SENT1	-	-
20	diagnosticado	diagnosticar	VMP00SM	-	-	89-102	144_QUEST_clinical_caseMIR	SENT1	-	-
21	de	de	SPS00	C0332285	atributo	103-105	144_QUEST_clinical_caseMIR	SENT1	-	-
22	psoriasis	psoriasis	NCFN000	C0033860_1	trastorno_1	106-115	144_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
23	severa	severo	AQ0FS0	C0205082	calificador	116-122	144_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
24	que	que	PR0CN000	-	-	123-126	144_QUEST_clinical_caseMIR	SENT1	-	-
25	ha	haber	VAIP3S0	-	-	127-129	144_QUEST_clinical_caseMIR	SENT1	-	-
26	recibido	recibir	VMP00SM	-	-	130-138	144_QUEST_clinical_caseMIR	SENT1	-	-
27	diversos	diverso	AQ0MP0	C0205395	calificador	139-147	144_QUEST_clinical_caseMIR	SENT1	-	-
28	tratamientos	tratamiento	NCMP000	C1273870#C0087111	procedimiento#régimen/tratamiento	148-160	144_QUEST_clinical_caseMIR	SENT1	-	-
29	en	en	SPS00	C1720294#C0332285	calificador#atributo	161-163	144_QUEST_clinical_caseMIR	SENT1	-	-
30	Dermatología	dermatología	NCFS000	C0011627	calificador	164-176	144_QUEST_clinical_caseMIR	SENT1	-	-
31	con	con	SPS00	C0332287	atributo	177-180	144_QUEST_clinical_caseMIR	SENT1	-	-
32	falta	falta	NCFS000	-	-	181-186	144_QUEST_clinical_caseMIR	SENT1	-	-
33	de	de	SPS00	C0332285	atributo	187-189	144_QUEST_clinical_caseMIR	SENT1	-	-
34	respuesta	respuesta	NCFS000	-	-	190-199	144_QUEST_clinical_caseMIR	SENT1	-	-
35	por	por	SPS00	C0678226	atributo	200-203	144_QUEST_clinical_caseMIR	SENT1	-	-
36	lo	el	DA0NS0	-	-	204-206	144_QUEST_clinical_caseMIR	SENT1	-	-
37	que	que	PR0CN000	-	-	207-210	144_QUEST_clinical_caseMIR	SENT1	-	-
38	deciden	decidir	VMIP3P0	-	-	211-218	144_QUEST_clinical_caseMIR	SENT1	-	-
39	en	en	SPS00	C1720294#C0332285	calificador#atributo	219-221	144_QUEST_clinical_caseMIR	SENT1	-	-
40	sesión	sesión	NCFS000	C0556657_1	procedimiento_1	222-228	144_QUEST_clinical_caseMIR	SENT1	-	-
41	clínica	clínico	AQ0FS0	C0556657_2	procedimiento_2	229-236	144_QUEST_clinical_caseMIR	SENT1	-	-
42	iniciar	iniciar	VMN0000	-	-	237-244	144_QUEST_clinical_caseMIR	SENT1	-	-
43	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	245-256	144_QUEST_clinical_caseMIR	SENT1	-	-
44	con	con	SPS00	C0332287	atributo	257-260	144_QUEST_clinical_caseMIR	SENT1	-	-
45	infliximab	infliximab	NC00SC0	C0666743	producto#sustancia	261-271	144_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
46	(	(	Fpa	-	-	272-273	144_QUEST_clinical_caseMIR	SENT1	-	-
47	anticuerpo	anticuerpo	NCMS000	C0003250_1	sustancia_1	273-283	144_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
48	monoclonal	monoclonal	AQ0CS0	C0003250_2	sustancia_2	284-294	144_QUEST_clinical_caseMIR	SENT1	I-Grp_Medicamento	-
49	dirigido	dirigir	VMP00SM	-	-	295-303	144_QUEST_clinical_caseMIR	SENT1	-	-
50	contra	contra	SPS00	C0521124	calificador	304-310	144_QUEST_clinical_caseMIR	SENT1	-	-
51	el	el	DA0MS0	-	-	311-313	144_QUEST_clinical_caseMIR	SENT1	-	-
52	factor	factor	NCMS000	C1562242_1	producto_1	314-320	144_QUEST_clinical_caseMIR	SENT1	-	-
53	de	de	SPS00	C1562242_2	producto_2	321-323	144_QUEST_clinical_caseMIR	SENT1	-	-
54	necrosis	necrosis	NCFN000	C1562242_3	producto_3	324-332	144_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
55	tumoral	tumoral	AQ0CS0	C1562242_4	producto_4	333-340	144_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
56	alfa	alfa	NCFS000	C1562242_5	producto_5	341-345	144_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
57	)	)	Fpt	-	-	345-346	144_QUEST_clinical_caseMIR	SENT1	-	-
58	.	.	Fp	-	-	346-347	144_QUEST_clinical_caseMIR	SENT1	-	-

1	Por	por	SPS00	C0678226	atributo	348-351	144_QUEST_clinical_caseMIR	SENT2	-	-
2	este	este	DD0MS0	-	-	352-356	144_QUEST_clinical_caseMIR	SENT2	-	-
3	motivo	motivo	NCMS000	-	-	357-363	144_QUEST_clinical_caseMIR	SENT2	-	-
4	,	,	Fc	-	-	363-364	144_QUEST_clinical_caseMIR	SENT2	-	-
5	se	se	P00CN000	-	-	365-367	144_QUEST_clinical_caseMIR	SENT2	-	-
6	le	le	PP3CSD00	C1292157#C0409974	hallazgo#trastorno	368-370	144_QUEST_clinical_caseMIR	SENT2	-	-
7	realiza	realizar	VMIP3S0	-	-	371-378	144_QUEST_clinical_caseMIR	SENT2	-	-
8	una	una		C0205447_1	calificador_1	379-382	144_QUEST_clinical_caseMIR	SENT2	-	-
9	prueba	prueba	NCFS000	-	-	383-389	144_QUEST_clinical_caseMIR	SENT2	-	-
10	de	de	SPS00	C0332285	atributo	390-392	144_QUEST_clinical_caseMIR	SENT2	-	-
11	tuberculina	tuberculina	NCFS000	C0034131	sustancia	393-404	144_QUEST_clinical_caseMIR	SENT2	-	-
12	con	con	SPS00	C0332287	atributo	405-408	144_QUEST_clinical_caseMIR	SENT2	-	-
13	una	una		C0205447_1	calificador_1	409-412	144_QUEST_clinical_caseMIR	SENT2	-	-
14	induración	induración	NCFS000	C0332534	anomalía_morfológica	413-423	144_QUEST_clinical_caseMIR	SENT2	-	-
15	de	de	SPS00	C0332285	atributo	424-426	144_QUEST_clinical_caseMIR	SENT2	-	-
16	16	16	Z	-	-	427-429	144_QUEST_clinical_caseMIR	SENT2	-	-
17	mm	mm	NCMN000	-	-	430-432	144_QUEST_clinical_caseMIR	SENT2	-	-
18	,	,	Fc	-	-	432-433	144_QUEST_clinical_caseMIR	SENT2	-	-
19	una	una		C0205447_1	calificador_1	434-437	144_QUEST_clinical_caseMIR	SENT2	-	-
20	radiografía	radiografía	NCFS000	C0039985_1	procedimiento_1	438-449	144_QUEST_clinical_caseMIR	SENT2	-	-
21	de	de	SPS00	C0039985_2	procedimiento_2	450-452	144_QUEST_clinical_caseMIR	SENT2	-	-
22	tórax	tórax	NCMN000	C0039985_3	procedimiento_3	453-458	144_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
23	que	que	PR0CN000	-	-	459-462	144_QUEST_clinical_caseMIR	SENT2	-	-
24	es	ser	VSIP3S0	-	-	463-465	144_QUEST_clinical_caseMIR	SENT2	-	-
25	normal	normal	AQ0CS0	C0205307	calificador	466-472	144_QUEST_clinical_caseMIR	SENT2	-	-
26	y	y	CC	C1706368	calificador	473-474	144_QUEST_clinical_caseMIR	SENT2	-	-
27	es	ser	VSIP3S0	-	-	475-477	144_QUEST_clinical_caseMIR	SENT2	-	-
28	remitido	remitir	VMP00SM	C1691010_1	calificador_1	478-486	144_QUEST_clinical_caseMIR	SENT2	-	-
29	a	a	SPS00	C1691010_2	calificador_2	487-488	144_QUEST_clinical_caseMIR	SENT2	-	-
30	la	el	DA0FS0	-	-	489-491	144_QUEST_clinical_caseMIR	SENT2	-	-
31	consulta	consulta	NCFS000	C3543841#C0009818	metadato_fundacional#procedimiento	492-500	144_QUEST_clinical_caseMIR	SENT2	-	-
32	de	de	SPS00	C0332285	atributo	501-503	144_QUEST_clinical_caseMIR	SENT2	-	-
33	Medicina	medicinar	VMM02S0	C0021782_1	calificador_1	504-512	144_QUEST_clinical_caseMIR	SENT2	-	-
34	Interna	interno	NCFS000	C0021782_2	calificador_2	513-520	144_QUEST_clinical_caseMIR	SENT2	-	-
35	para	para	SPS00	C0521125	calificador	521-525	144_QUEST_clinical_caseMIR	SENT2	-	-
36	valoración	valoración	NCFS000	-	-	526-536	144_QUEST_clinical_caseMIR	SENT2	-	-
37	.	.	Fp	-	-	536-537	144_QUEST_clinical_caseMIR	SENT2	-	-

